"Medical Oncology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subspecialty of internal medicine concerned with the study of neoplasms.
Descriptor ID |
D008495
|
MeSH Number(s) |
H02.403.429.515
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medical Oncology".
Below are MeSH descriptors whose meaning is more specific than "Medical Oncology".
This graph shows the total number of publications written about "Medical Oncology" by people in this website by year, and whether "Medical Oncology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2010 | 3 | 0 | 3 |
2011 | 2 | 2 | 4 |
2012 | 1 | 2 | 3 |
2013 | 1 | 1 | 2 |
2014 | 3 | 1 | 4 |
2016 | 3 | 2 | 5 |
2017 | 3 | 2 | 5 |
2018 | 3 | 3 | 6 |
2019 | 2 | 0 | 2 |
2020 | 7 | 6 | 13 |
2021 | 7 | 2 | 9 |
2022 | 0 | 3 | 3 |
2023 | 0 | 2 | 2 |
2024 | 1 | 2 | 3 |
2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medical Oncology" by people in Profiles.
-
Screening for Financial Toxicity in Oncology Research and Practice: A Narrative Review. JCO Oncol Pract. 2025 Jan; 21(1):5-11.
-
Cost Conversations to Mitigate the Effects of Financial Toxicity in Oncology: Current State, Opportunities, and Barriers. JCO Oncol Pract. 2025 Jan; 21(1):23-28.
-
Mentor communication skills training: development, feasibility, and preliminary efficacy. BMC Med Educ. 2024 Jun 10; 24(1):646.
-
Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2024 Jul 01; 42(19):2336-2357.
-
Health Care Lobbying and Oncology. J Natl Compr Canc Netw. 2024 04 19; 22(4):226-230.
-
Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020. Mayo Clin Proc. 2023 Dec; 98(12):1767-1773.
-
The NCI-MATCH trial: lessons for precision oncology. Nat Med. 2023 Jun; 29(6):1349-1357.
-
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies. J Clin Oncol. 2023 Apr 10; 41(11):2020-2028.
-
Communicating bad news to patients and families in African oncology settings. Psychooncology. 2023 01; 32(1):47-57.
-
Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. Am J Health Syst Pharm. 2022 02 18; 79(5):364-384.